Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurobiological disorder. Common symptoms are inattention, hyperactivity, impulsivity, and executive functions deficit, often with comorbidities. Main treatment involves pharmacological and non-pharmacological therapies (cognitive-behavioral therapy, psycho-pedagogical programs). Emerging non-pharmacological treatments include manual therapies (MTs) in mental health. Several MT techniques have shown effectiveness in ADHD. The objectives of this study are as follows: (a) to assess short-term effects and persistence of an MT program on neuropsychological (hyperactivity index through the Conners’ Global Index [CGI]) and neurophysiological (time–frequency domain parameters of heart rate variability [HRV]) variables in ADHD children, and (b) to test the feasibility of the design. This study was approved by the Parc Tauli Corporation Clinical Research Ethics Board (#2017311). Pilot, controlled, multidisciplinary study of eight children with ADHD randomly assigned to control group (CG; n = 4) and intervention group (IG; n = 4). Both followed multimodal treatment, and IG also received an MT program per week for 4 weeks. A physiotherapist and a psychologist analyzed short-term effects (1-week post-program) and persistence (36 weeks). Eight children (boys, 62.5%; girls, 37.5%) with an average age of 10.375 ± 0.74 years were included. Baseline HRV parameters showed basal sympathetic predominance. The MT program increased the parasympathetic activity, which was significantly maintained at 1 to 36 weeks; there were no changes in CG. One-week post-program IG showed significant CGI reduction (–7 points, p = .016*), CG without changes ( p = .41), with significant differences CG – IG ( p = .0097*), and very large effect size ( d = 2.235); 36 weeks post-program showed no effects (IG, p = .293; CG, p = .247), without differences CG – IG ( p = .369). The MT program reduced the hyperactivity index with a 1-week persistence and increased the parasympathetic activity with a 36-week persistence. More investigations are needed to generalize the outcomes. Additional research is planned to further explore the possibilities of MT in psychiatric disorders with autonomic imbalances.

Highlights

  • IntroductionAttention-deficit/hyperactivity disorder (ADHD) is a neurobiological disorder (global prevalence: 5%–7%, boys: 2.5%– 5.6%, girls: 1%) with a genetic substrate, and symptoms occur early in pediatric age

  • Attention-deficit/hyperactivity disorder (ADHD) is a neurobiological disorder with a genetic substrate, and symptoms occur early in pediatric age

  • The hyperactivity index (CGI) and Heart rate variability (HRV) parameters were collected at 1 and 36 weeks after the last intervention in both groups; they were compared within each group and between groups to study the persistence of the effects of each program and to determine differences between both programs

Read more

Summary

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a neurobiological disorder (global prevalence: 5%–7%, boys: 2.5%– 5.6%, girls: 1%) with a genetic substrate, and symptoms occur early in pediatric age. ADHD shows three main presentations: predominantly inattentive, hyperactive–impulsive, and combined inattentive and hyperactive–impulsive. Main treatment involves pharmacological (methylphenidate/atomoxetine/ dexamfetamine) and non-pharmacological therapies (cognitive-behavioral, comorbidities treatment, and tailor-made educational psycho-pedagogical school programs; Diagnostic and Statistical Manual of Mental Disorders [5th ed.; DSM-5]; American Psychiatric Association [APA], 2013)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call